Diabetes mellitus is a group of diseases differing in etiology and pathogenesis, characterized by impaired carbohydrate metabolism and hyperglycemia and typical symptoms of polyuria, polydipsia, and/or polyphagia (1) . A patient is diagnosed as having diabetes based on the blood glucose concentrations with two well-known cut-off values, 7.0 mmol/L (126 mg/dL) and 11.1 mmol/L (200 mg/dL). Blood glucose concentration is also a predictive marker for diabetic complications. Thus, in clinical practice, accurate blood glucose data are essential for the diagnosis and management of diabetes (1) .
It is critical that laboratories perform glucose testing in a reproducible and accurate manner. According to generally accepted guidelines, analytical imprecision should be 3.3% or less, bias should be 2.5% or less, and total error should be 7.9% or less (2) . Satisfactory precision can be achieved by keeping up with standard laboratory operating procedures and the implementation of quality assurance processes. However, determination of bias is possible only by comparison with the test results performed using an officially approved reference method.
Many countries have their own external quality assessment programs (EQAP) (3) . In most instances, the laboratories using the same method or equipment are categorized as peer groups to determine target values. In Korea, the Korean Association of Quality Assurance for Clinical Laboratories (KAQACL), an officially approved organization that operates an EQAP, assesses and reports the proficiency testing (PT) results of each participating laboratory, with the mean value of the peer group being considered as the target value. Recently, with the increased interest in trueness of tests, efforts to improve the reliability of PT by comparing EQAP results with target values measured with a reference measurement procedure (RMP) have been started.
Isotope dilution/gas chromatography/mass spectrometry (ID/GC/MS) is the reference procedure for glucose measurement approved by the German Society of Clinical Chemistry and the American National Institute of Standards and Technology (NIST) (4) . Several prestigious European laboratories using this method are recognized as officially approved institutions for glucose reference measurement services.
In the present study, we report glucose measurements on 12 samples that had been sent, by the Clinical Chemistry Division of KAQACL in 2008, to participating laboratories for laboratory quality assessment. Target values were obtained using an ID/GC/MS methodology in an approved laboratory. These were compared with data from participating laboratories to obtain a mean bias of glucose measurements in Korean clinical laboratories. The proportion of laboratories yielding data within recommended limits was estimated.
The glucose concentrations of 12 PT samples, lyophilized human serum-based control material, provided by the Clinical Chemistry Division of KAQACL in 2008, were measured using ID/GC/MS to obtain target values by Linköping University (Sweden), an officially approved reference laboratory for glucose measurement. Specimens were delivered and stored at room temperature before measurement.
All specimens were dissolved in 5 mL of clinical laboratory reagent water (CLRW), and glucose concentrations in two vials of each sample were measured three times. The mean value of the six measurements was used as the target value.
Samples were deproteinated and derivatized, mixed with an internal standard containing the w
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Cx isotope, and glucose Test samples with statistically significant difference in average glucose concentrations between the glucose oxidase method group and the hexokinase/UV method group (p-0.05). SD, standard deviation; ID/GC/MS, isotope dilution/gas chromatography/mass spectrometry. concentrations were then measured using GC/MS, as described previously (4, 5) .
The results of glucose PT in 2008 were analyzed. After outliers were removed, the mean, standard deviation, and coefficient of variation (CV) for the data from each sample were calculated. More than 95% of participating laboratories used the glucose oxidase/peroxidase or the hexokinase/UV method, and our statistical analyses examined data from total laboratories, those using the glucose oxidase method and those using the hexokinase/UV technique. The average glucose concentrations of the glucose oxidase group and hexokinase/UV group in each test sample were compared using Students t-test with SPSS statistical software version 12 (SPSS Inc., Chicago, IL, USA). p-Values-0.05 were considered statistically significant.
By the comparison of the mean values of PT results obtained in 2008 with the target values measured with RMP, the mean bias for each trial was calculated. Biases were estimated for total laboratories, for those using the glucose oxidase method and for those using the hexokinase/UV technique.
We also evaluated the overall bias of glucose in clinical laboratories. For these calculations, the number of laboratories reporting data within a 2.5% error range from the target value (obtained by ID/GC/MS), and the number of laboratories meeting the 2.5% criterion as determined by the calculated mean glucose level of each sample, were compared.
Approximately 75% of participating Korean laboratories used the hexokinase/UV method, and about 20% the glucose oxidase technique. The mean glucose concentrations of the glucose oxidase group were higher than those of hexokinase/ UV group with statistically significant difference in test samples 1, 4, 7, 9, 10 (p-0.05). However, no significant difference was observed in the other test samples ( Table 1) .
Comparison of values from ID/GC/MS measurements and the mean values of each sample indicated that mean values obtained by Korean laboratories were slightly higher than those measured using the RMP. In addition, average glucose concentrations reported by laboratories using the glucose oxidase method were higher than those reported by the laboratories using the hexokinase/UV method, for most of the samples. The mean bias values for total laboratories, for laboratories using the glucose oxidase method and for laboratories using the hexokinase/UV technique, were 1.9%, 2.6%, and 1.8%, respectively (Table 1 and Figure 1) .
The calculated bias for glucose measurements were determined at 7.0 mmol/L (126 mg/dL) and 11.1 mmol/L (200 mg/dL) as these are clinical decision thresholds. Linear regression showed that bias was -2% when data from all laboratories were combined, and for laboratories using the hexokinase/UV method. However, for laboratories employing the glucose oxidase method, bias was q2.7% at a glucose concentration of 7.0 mmol/L (126 mg/dL), which exceeds the recommended threshold value of 2.5% ( Figure  1 ).
Our analysis of 8581 individual measurements relative to RMP results indicated that 47.0% had bias values -2.5%. As for the data from glucose oxidase method group, 36.6% (610/1666) of data points were within 2.5% bias range, and for those from the hexokinase/UV method group, 49.6% (3290/6627) of data points were within the 2.5% bias range. Meanwhile, 57.4% of measurements had bias values of -2.5% when the mean value of each trial was considered.
Glucose oxidase and hexokinase/UV methods are most commonly used to measure glucose concentration in Korean laboratories. These methods have been consistently employed over time, with no significant change in the proportion of use in recent years (6) . Despite the efforts by a lot of EQAP authorities worldwide, the commutability of PT materials is frequently raised as an important issue. Although freeze-drying is the most widely used method for preparation of quality control material, we cannot exclude the possibility that the matrices of freeze-dried test samples and fresh blood specimens differ. Indeed, a possible matrix effect has been described in freezedried materials. According to a paper reported by College of American Pathologists (CAP), conventionally prepared lyophilized PT samples were not commutable with freshly frozen specimens (7) . In contrast, a recent report from a European EQA program suggested that bias attributable to freeze-drying of materials is clinically meaningless, and freeze-dried materials could be appropriately used for external quality assurance. The cited program reported a mean bias of 0.7% in glucose test data (8) .
Such contradictory results may be at least partly attributable to differences in survey size, analytical methods, and/ or reagents employed in the various laboratories. More than 6000 laboratories participated in the CAP survey, and vendor-or instrument-specific peer group averages were compared. In the EQA SEKK (European) survey, fewer than 200 laboratories participated, and the average data of groups using the same methods were assessed. These methodological differences make it difficult to compare the data from the two surveys. Furthermore, laboratories participating in the SEKK program performed a considerable number of nonhomogeneous tests, using combinations of various instruments, calibrators, and reagents. The practices of the SEKK program differ from those of the CAP, which reviews homogenous test data (9) . Potential bias attributable to lyophilization and transportation of PT materials thus remains an open question.
The Korean EQA program described in the present study is a national PT scheme, similar to the European EQA SEKK system. Continuous monitoring through the Korean EQA program plays an important role in performance improvement of clinical laboratories. However, the number of participating laboratories is relatively small, and homogenous tests are not commonly performed in Korea. This means that the Korean EQA program does not appear to perform the post-market vigilance function required by the European Directive for in vitro diagnostic medical devices (IVD-MDs) (10) .
The analysis of the results of the glucose test showed a mean CV smaller than 5%, and a positive bias of approximately 2% compared to the value measured with the RMP. These indicate reliable testing performance as a whole, but consistently higher glucose concentrations in Korean clinical laboratories. Based on the results of this study, we could conclude that further effort should be needed to improve the trueness of glucose testing in Korean clinical laboratories.
Conflict of interest statement
Authors' conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
